Pharmaceutical Pricing and Healthcare Access

Healthcare coverage and costs remain prime concerns for FDA as the number of uninsured Americans continues to grow.

Related Content:

Regulatory WatchPharmaceutical Technology-03-02-2004

Major Challenges Ahead for FDA and Pharma

FDA Grapples with the Promise and Perils of Gene Therapy

Pandemic Alters Policies and Practices for Drug Development and Regulation